Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KARS1 | Q15046 | 1/20 | 0.56 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.41 |
| ▸ | POLA1 | P09884 | 4/20 | 0.40 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.40 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.40 |
| ▸ | FDPS | P14324 | 6/20 | 0.39 |
| ▸ | BCL9 | O00512 | 3/20 | 0.38 |
| ▸ | CTNNB1 | P35222 | 3/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | USP2 | O75604 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | PTGES | O14684 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29507670 | 1.00 | KARS1 (0.56) | KARS1CYP19A1POLA1NR1I2OPRK1 | |
| SCHEMBL18290296 | 0.86 | KARS1 (0.52) | KARS1POLA1FDPSCYP3A4MAPT | |
| Ferruginol SCHEMBL5315022 | 0.81 | KARS1 (0.73) | KARS1CYP19A1POLA1NR1I2OPRK1 | |
| Ferruginol SCHEMBL13423521 | 0.81 | KARS1 (0.73) | KARS1CYP19A1POLA1NR1I2OPRK1 | |
| Ferruginol SCHEMBL155580 | 0.81 | KARS1 (0.73) | KARS1CYP19A1POLA1NR1I2OPRK1 | |
| Hinokiol SCHEMBL18290363 | 0.79 | KARS1 (0.63) | KARS1CYP19A1POLA1NR1I2OPRK1 | |
| Hinokiol SCHEMBL854936 | 0.79 | KARS1 (0.63) | KARS1CYP19A1POLA1NR1I2OPRK1 | |
| Sempervirol SCHEMBL10524412 | 0.76 | KARS1 (0.66) | KARS1CYP19A1NR1I2OPRK1FDPS | |
| Sempervirol SCHEMBL10524413 | 0.76 | KARS1 (0.66) | KARS1CYP19A1NR1I2OPRK1FDPS | |
| Sempervirol SCHEMBL29495146 | 0.76 | KARS1 (0.66) | KARS1CYP19A1NR1I2OPRK1FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118121593-B | Pharmaceutical composition for preventing and/or treating Alzheimer disease and application thereof | 首都医科大学宣武医院 | 2025-02-14 | — | — | CN | claimed |
| CN-122056926-A | Probiotic composition containing melatonin and application of composition in sleep | 南京北极光生物科技有限公司 | 2026-05-19 | — | — | CN | disclosed |
| US-20260102376-A1 | USE OF DIHYDROTANSHINONE I DERIVATIVE IN PREPARATION OF DRUG FOR TREATING CEREBRAL CAVERNOUS MALFORMATION | Nanjing University of Chinese Medicine (CN) | 2026-04-16 | — | — | US | disclosed |
| CN-120081733-A | Compound with anti-tumor effect in Salvia officinalis, separation method and application | 华中科技大学 | 2025-06-03 | — | — | CN | disclosed |
| CN-116687945-B | Application of compound in preparing scar reducing agent and scar removing external agent | 黑龙江龙德药业有限公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-119936250-A | Construction method of ginseng and motherwort blood-nourishing particle fingerprint and fingerprint thereof | 陕西白鹿制药股份有限公司 | 2025-05-06 | — | — | CN | disclosed |
| US-20250137015-A1 | YEAST PLATFORM FOR RENEWABLE INDUSTRIAL TERPENE PRODUCTION | Wang, Zhen (US) | 2025-05-01 | — | — | US | disclosed |
| CN-119380826-B | Chinese patent medicine network pharmacology analysis method and model construction method based on multiscale information entropy | 首都医科大学附属北京朝阳医院 | 2025-04-08 | — | — | CN | disclosed |
| CN-118853691-B | Salvia miltiorrhiza gene SmWRKY and application thereof | 陕西省西安植物园(陕西省植物研究所) | 2025-04-08 | — | — | CN | disclosed |
| CN-119709773-A | Application of SmbHLH130,130 gene in improving tanshinone and salvianolic acid content in red sage root | 浙江理工大学 | 2025-03-28 | — | — | CN | disclosed |
| CN-113791154-B | Method for identifying chemical components in Xuebijing injection | 天津中医药大学 | 2023-06-23 | — | — | CN | disclosed |
| CN-116183790-A | Multi-index component content of ginseng and immortal pulse-raising oral liquid and fingerprint detection method thereof | 山东步长制药股份有限公司 | 2023-05-30 | — | — | CN | disclosed |
| CN-113248514-B | Dimethyldeuterated carnosol, preparation method thereof and application thereof in preparation of drugs for treating cachexia | 华东师范大学 | 2023-03-31 | — | — | CN | disclosed |
| CN-115154562-A | A topical composition for treating cancer, and its preparation method | 何建设 | 2022-10-11 | — | — | CN | disclosed |
| CN-115058438-A | Gene SmDNMT2 for efficiently promoting accumulation of tanshinone and application thereof | 浙江理工大学 | 2022-09-16 | — | — | CN | disclosed |
| US-20220291237-A1 | Gene Expression Inflammatory Age and Its Uses | Edifice Health, Inc. (US) | 2022-09-15 | — | — | US | disclosed |
| CN-114948881-A | Octreotide acetate microsphere and preparation method thereof | 烟台大学 | 2022-08-30 | — | — | CN | disclosed |
| CN-114836449-A | Gene SmCMT3 for efficiently promoting accumulation of tanshinone and application thereof | 浙江理工大学 | 2022-08-02 | — | — | CN | disclosed |
| CN-114761572-A | Cannabinoid concentrates and isolates, methods of obtaining the same, and uses thereof | 赫博利生物科技股份公司 | 2022-07-15 | — | — | CN | disclosed |
| CN-111667889-B | Method for predicting content of quality marker in salvia miltiorrhiza | 山东中医药大学 | 2022-03-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260102376-A1 | USE OF DIHYDROTANSHINONE I DERIVATIVE IN PREPARATION OF DRUG FOR TREATING CEREBRAL CAVERNOUS MALFORMATION | CACNA1A, SDHA, MVD | KARS1 1970/4885CYP19A1 687/4885POLA1 3073/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.